Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on April 24, 2025

CoreCard Corporation Schedules First Quarter 2025 Earnings Release and Conference Call
NORCROSS, Ga., April 24, 2025 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, intends to hold an investor …

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™
(IMAGES BELOW) Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast cancer patient Treatment well-tolerated and patient remains on study with stable disease elsewhere Sustained clinical response …

Applied Materials to Report Fiscal Second Quarter 2025 Results on May 15, 2025
SANTA CLARA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that it will hold its fiscal second quarter 2025 earnings conference call on Thursday, May 15, 2025, at 4:30 p.m. ET / 1:30 p.m. PT. The call will be webcast …

MACOM to Report Second Quarter 2025 Financial Results on May 8, 2025
LOWELL, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI) plans to announce financial results for its second quarter ended April 4, 2025, before market open on Thursday, May 8, 2025. In conjunction …

Kura Oncology to Report First Quarter 2025 Financial Results
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will …

Ace Vision Group Announces Initial Close of $29.4 Million Series B Financing Round
Funding supports the commercial product development of VisioLite® Device and Laser Scleral Microporation Human Clinical Study. Capital raised to date provides strong financial position to prepare the device for regulatory trials and submissions. BOSTON, …

Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for late 2025 - WALTHAM, Mass., April 24, 2025 (GLOBE …

Plato Gold Reports on 2024 Year-End Results
Toronto,, April 24, 2025 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) an exploration company with a portfolio of properties in Northern Ontario and Santa Cruz, Argentina is …

Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer
AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potent monotherapy with broad application in oncology Lead product AVC-S-101 is a TROP2-targeting booster being developed for non-small cell lung cancer and multiple …

TruGolf Improves Balance Sheet with Agreement to Eliminate All Convertible Notes
All Convertible Notes …

SEED Therapeutics Reports Breakthroughs for Two Targeted Protein Degradation Projects at AACR Annual Meeting in Chicago
Two PROTAC synergy using two E3 ligases for achieving levels of degradation of KRAS G12D not achieved with single PROTACs, will be presented by the lab of Luca Busino, PhD, from the University of Pennsylvania, on April 27th SEED’s first IND candidate …

Diginex and Baker Tilly Singapore Announce Strategic Alliance to Deliver diginexESG Platform to Baker Tilly ’s Clients
LONDON, April 24, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex”) (NASDAQ: DGNX), a leading impact technology company specializing in environmental, social, and governance (ESG) solutions, and Baker Tilly Singapore (“Baker Tilly”), a globally …

Mitolyn Reviews 2025: Why This Non-Stimulant Best Weight Loss Supplement Is a Game-Changer for Fat Burn and Metabolism
Tallmadge, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- As more health-conscious individuals seek safer, stimulant-free alternatives for weight management in 2025, natural supplements are becoming the gold standard. Crash diets, intense fitness programs, and …

ParaZero Achieves Extended Class C5 Certification for DJI Mavic 3 Series, Expanding European Market Access
Expanded approval now includes Mavic 3 Pro and Mavic 3 Pro Cine, completing regulatory pathway for enterprise drone operations in urban and sensitive areas TEL AVIV, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the …

CRB Appoints Ken Olson as Chief Financial Officer
Kansas City, Missouri, April 24, 2025 (GLOBE NEWSWIRE) -- CRB, a leading global provider of sustainable engineering, architecture, construction and consulting solutions to the life sciences and food and beverage industries, today announced the appointment …

Gilat to Report First Quarter 2025 Results on Monday, May 19th
PETAH TIKVA, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today announced that it will release its first quarter 2025 …

Ligand to Report First Quarter 2025 Financial Results on May 8, 2025
JUPITER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report first quarter 2025 financial results before the opening of the U.S. financial markets on Thursday, May 8, 2025. The …

Axonius Appoints Robert Skinner (USAF Retired) to Axonius Federal Systems Board
RESTON, Va., April 24, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the appointment of (USAF Ret.) Robert Skinner to the Axonius Federal Systems …

Kymera Therapeutics to Unveil New Oral Immunology Program and Report First Quarter 2025 Financial Results on May 9, 2025
Watertown, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that it …

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
WHO WHAT WHERE WHEN WHY Nuwellis, Inc. Issuance of U.S. Patent No. 12,280,007. United States Patent and Trademark Office April 22, 2025 To protect a novel self-emptying fluid bag design that improves nursing workflow while maintaining system accuracy. …